Adjustment of Eculizumab Dosage Pattern in Patients with Atypical Hemolytic Uremic Syndrome with Suboptimal Response to Standard Treatment Pattern

In patients with atypical hemolytic uremic syndrome (aHUS), complement blocking by eculizumab rapidly halts the process of thrombotic microangiopathy and it is associated with clear long-term hematologic and renal improvements. Eculizumab treatment consists of a 4-week initial phase with weekly IV a...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Case Rep Nephrol
Main Authors: García Monteavaro, Camino, Peralta Roselló, Carmen, Quiroga, Borja, Baltar Martín, José María, Castillo Eraso, Lorena, de Álvaro Moreno, Fernando, Martínez Vea, Alberto, Visus-Fernández de Manzanos, María Teresa
Formáid: Artigo
Teanga:Inglês
Foilsithe: Hindawi Publishing Corporation 2016
Ábhair:
Case Report
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153492/
https://ncbi.nlm.nih.gov/pubmed/28025630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/7471082
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla